Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the etiological agent of coronavirus disease 2019 (COVID-19), may manifest as a life-threatening respiratory infection with systemic complications. Clinical manifestations among children are generally less severe than those seen in adults, but critical cases have increasingly been reported in infants less than 1 year of age. We report a severe case of neonatal COVID-19 requiring intensive care and mechanical ventilation, further complicated by a multidrug-resistant Enterobacter asburiae super-infection. Chest X-rays, lung ultrasound, and chest computed tomography revealed extensive interstitial pneumonia with multiple consolidations, associated with persistent increased work of breathing and feeding difficulties. SARS-CoV-2 RNA was detected in respiratory specimens and stools, but not in other biological samples, with a rapid clearance in stools. Serological tests demonstrated a specific SARS-CoV-2 antibody response mounted by the neonate and sustained over time. The therapeutic approach included the use of enoxaparin and steroids which may have contributed to the bacterial complication, underlying the challenges in managing neonatal COVID-19, where the balance between viral replication and immunomodulation maybe even more challenging than in older ages.

Marsico C., Capretti M.G., Aceti A., Vocale C., Carfagnini F., Serra C., et al. (2022). Severe neonatal COVID-19: Challenges in management and therapeutic approach. JOURNAL OF MEDICAL VIROLOGY, 94(4), 1701-1706 [10.1002/jmv.27472].

Severe neonatal COVID-19: Challenges in management and therapeutic approach

Marsico C.;Capretti M. G.
;
Aceti A.;Vocale C.;Serra C.;Campoli C.;Lazzarotto T.;Corvaglia L.
Ultimo
2022

Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the etiological agent of coronavirus disease 2019 (COVID-19), may manifest as a life-threatening respiratory infection with systemic complications. Clinical manifestations among children are generally less severe than those seen in adults, but critical cases have increasingly been reported in infants less than 1 year of age. We report a severe case of neonatal COVID-19 requiring intensive care and mechanical ventilation, further complicated by a multidrug-resistant Enterobacter asburiae super-infection. Chest X-rays, lung ultrasound, and chest computed tomography revealed extensive interstitial pneumonia with multiple consolidations, associated with persistent increased work of breathing and feeding difficulties. SARS-CoV-2 RNA was detected in respiratory specimens and stools, but not in other biological samples, with a rapid clearance in stools. Serological tests demonstrated a specific SARS-CoV-2 antibody response mounted by the neonate and sustained over time. The therapeutic approach included the use of enoxaparin and steroids which may have contributed to the bacterial complication, underlying the challenges in managing neonatal COVID-19, where the balance between viral replication and immunomodulation maybe even more challenging than in older ages.
2022
Marsico C., Capretti M.G., Aceti A., Vocale C., Carfagnini F., Serra C., et al. (2022). Severe neonatal COVID-19: Challenges in management and therapeutic approach. JOURNAL OF MEDICAL VIROLOGY, 94(4), 1701-1706 [10.1002/jmv.27472].
Marsico C.; Capretti M.G.; Aceti A.; Vocale C.; Carfagnini F.; Serra C.; Campoli C.; Lazzarotto T.; Corvaglia L.
File in questo prodotto:
File Dimensione Formato  
Marsico_Manuscript_revised.pdf

accesso aperto

Tipo: Postprint
Licenza: Licenza per accesso libero gratuito
Dimensione 705.36 kB
Formato Adobe PDF
705.36 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11585/882411
Citazioni
  • ???jsp.display-item.citation.pmc??? 9
  • Scopus 15
  • ???jsp.display-item.citation.isi??? 11
social impact